Steinberg Sarit
Director de Operaciones en Israel Biotech Fund .
Perfil
Sarit Steinberg is a Partner at Israel Biotech Fund since 2015.
Prior to this, she worked as the General Counsel at Immune Pharmaceuticals Ltd.
from 2013 to 2015.
Ms. Steinberg holds a graduate degree from the London School of Economics & Political Science (2003) and a graduate degree from Queen Mary University of London (2002).
Cargos activos de Steinberg Sarit
Empresas | Cargo | Inicio |
---|---|---|
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Director de Operaciones | 01/02/2020 |
Antiguos cargos conocidos de Steinberg Sarit.
Empresas | Cargo | Fin |
---|---|---|
Immune Pharmaceuticals Ltd.
Immune Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Immune Pharmaceuticals, Inc., Immune Pharmaceuticals Ltd. develops pharmaceutical products for the treatment of cancer and pain. The company is based in Herzliya-Pituach, Israel. Immune Pharmaceuticals was acquired by EpiCept Corp. on August 26, 2013 for $21.43 million. | Consejero General | 01/05/2015 |
Formación de Steinberg Sarit.
London School of Economics & Political Science | Graduate Degree |
Queen Mary University of London | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Immune Pharmaceuticals Ltd.
Immune Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Immune Pharmaceuticals, Inc., Immune Pharmaceuticals Ltd. develops pharmaceutical products for the treatment of cancer and pain. The company is based in Herzliya-Pituach, Israel. Immune Pharmaceuticals was acquired by EpiCept Corp. on August 26, 2013 for $21.43 million. | Health Technology |
- Bolsa de valores
- Insiders
- Steinberg Sarit